The year in damages in the US

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The year in damages in the US

Compared to 2013, this year has seen fewer blockbuster damages awards, with none of more than $500 million. But courts still awarded more than $100 million in eight cases

The largest award came out of the District of Delaware, which ordered Philips to pay Masimo $467 million for infringing patents covering technology used in fingertip devices that measure blood oxygen and pulse rates.

This followed the same court in January awarding Edwards LifeScience $394 million for Medtronic CoreValve for infringing patents covering a heart-valve device. The two companies later agreed to settle all global patent litigation in May, with Edwards LifeSciences paying a $750 million one-time payment and ongoing royalty payments.

Carnegie Melon University, ViaSatr, Alfred E Mann Foundation, WesternGeco, Apple and Power Integrations were also awarded damages of more than $100 million in 2014.

This compares with 2013 when two awards of more than $500 million were given. DuPont was ordered to pay $1 billion of damages to Monsanto in a GMO seed case. And Samsung was ordered to pay Apple $599 million in one of two large awards that year.

Managing IP will be publishing an in-depth look at the year in damages in early January. 


Top damages awards 2014

Rank

Against

Beneficiary

Case

Court

Total damages

1

Philips Electronics North America

Masimo Corporation

Masimo Corporation v Philips Electronics North America Corporation

DED

$467m

2

Medtronic CoreValve

Edwards Lifesciences

Edwards Lifesciences v Medtronic Corevalve

DED

$394m

3

Marvell Technology Group

Carnegie Mellon University

Carnegie Mellon University v Marvell Technology Group

PAWD

$367m

4

Space Systems/Loral

ViaSat

Viasat v Space Systems/Loral

CASD

$283m

5

Cochlear Corporation

Alfred E Mann Foundation For Scientific Research

Alfred E Mann Foundation for Scientific Research v Cochlear Corporation

CACD

$131m

6

Samsung Electronics

Apple

Apple v Samsung Electronics

CAND

$120m

7

ION Geophysical Corporation

WesternGeco

WesternGeco v ION Geophysical Corporation

TXSD

$115m

8

Fairchild Semiconductor International

Power Integrations

Power Integrations v Fairchild Semiconductor International

CAND

$105m

9

Google

SimpleAir

SimpleAir v Google

TXED

$85m

10

Sorenson Communications

Ultratec

Ultratec v Sorenson Communications

WIWD

$44m

Source: Docket Navigator

more from across site and SHARED ros bottom lb

More from across our site

Monetisation is standing at the forefront of patent development, and one firm says AI is increasingly being deployed
Data centres are being built across the US, prompting patent disputes, but Texas’s thriving tech industry and patent-ready courts make the state particularly ‘ripe’ for litigation
Carpmaels & Ransford is set to bolster its UK attorney team with the appointment of Simmons & Simmons’s head of IP in the UK
Updates on Nokia’s licensing strides and a surge in patent activity around battery recycling in Australia were also among the top talking points
To mark International Day Against Child Labour, Matteo Amerio at Corsearch says the people inside businesses who can identify counterfeiting risks must be given the tools and authority to act
With genuine equity at IP firms becoming rarer, securing partnership is harder than ever, but increased transparency is also making climbing the ladder more predictable
Yossi Sivan explains how Israeli judgment is a pro-brand owner departure from the norm and why it sends a strong message that corporate structures are not always a shield
Halim Shehadeh, group CEO of IP firm CWB, says that in the rush to discuss what AI can do, IP firms are overlooking the more important question of whether they are ready
Caitlin Heard, who formally joined the firm from CMS last month, says she is excited by the ‘energy’ of the London office
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Gift this article